Two Sigma Investments
VIVS

Two Sigma Investments’s VivoSim Labs VIVS Stock Holding History

Two Sigma Investments’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,830
Closed -$21.4K – 5020
2025
Q4 		$21.4K Sell
11,830
-11,362
-49% -$27K ﹤0.01% 3993
2025
Q3 		$67.7K Buy
+23,192
New +$54.9K ﹤0.01% 3516
2022
Q1 		– Sell
-1,989
Closed -$87K – 4572
2021
Q4 		$87K Buy
+1,989
New +$128K ﹤0.01% 4083
2020
Q3 		– Sell
-67
Closed -$9K – 3645
2020
Q2 		$9K Sell
67
-98
-59% -$11.9K ﹤0.01% 2880
2020
Q1 		$16K Sell
165
-31
-16% -$2.5K ﹤0.01% 2978
2019
Q4 		$17K Sell
196
-243
-55% -$22.7K ﹤0.01% 3590
2019
Q3 		$27K Buy
439
+76
+21% +$6.4K ﹤0.01% 3378
2019
Q2 		$46K Buy
363
+200
+123% +$37.8K ﹤0.01% 3246
2019
Q1 		$39K Buy
+163
New +$41K ﹤0.01% 2947

Other funds holding VIVS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

Two Sigma Investments's VIVS Position: Q1 2026 in Review

Two Sigma Investments sold out of VivoSim Labs (VIVS) in Q1 2026, closing a stake of 11,830 shares — an estimated $21.4K sold.

Two Sigma Investments first reported a position in VIVS in Q1 2019 and held it in 9 quarters. The position peaked at $87K in Q4 2021. 24 funds tracked by Wall St. Rank hold VIVS as of Q1 2026.

  • Two Sigma Investments reported no remaining VivoSim Labs position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Investments sold 11,830 VivoSim Labs shares in Q1 2026, an estimated $21.4K.
  • Two Sigma Investments first reported a position in VivoSim Labs in Q1 2019 and held it in 9 quarters.
  • Two Sigma Investments's VivoSim Labs position peaked at $87K in Q4 2021.
  • 24 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.